Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 3
1974 3
1975 7
1976 3
1977 2
1978 2
1980 3
1981 7
1982 5
1984 5
1985 2
1986 3
1987 5
1988 1
1989 3
1990 3
1991 3
1992 2
1993 4
1994 1
1996 8
1997 2
1998 3
1999 4
2000 4
2001 5
2002 2
2004 2
2005 7
2006 5
2007 5
2008 2
2009 5
2010 4
2011 8
2012 5
2013 3
2014 5
2015 7
2016 7
2017 3
2018 2
2019 1
2020 2
2021 4
2022 7
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
Author's response.
Tanimoto S, Kaliner M, Ellis AK, Lowenthal R. Tanimoto S, et al. Among authors: lowenthal r. Ann Allergy Asthma Immunol. 2023 Sep;131(3):399. doi: 10.1016/j.anai.2023.06.019. Ann Allergy Asthma Immunol. 2023. PMID: 37661173 No abstract available.
Reply.
Casale TB, Ellis AK, Nowak-Wegrzyn A, Kaliner M, Lowenthal R, Tanimoto S. Casale TB, et al. Among authors: lowenthal r. J Allergy Clin Immunol. 2024 Feb;153(2):536-537. doi: 10.1016/j.jaci.2023.10.030. Epub 2023 Dec 6. J Allergy Clin Immunol. 2024. PMID: 38069978 No abstract available.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.
Myelodysplastic syndromes.
Lowenthal RM, Marsden KA. Lowenthal RM, et al. Int J Hematol. 1997 Jun;65(4):319-38. doi: 10.1016/s0925-5710(96)00566-x. Int J Hematol. 1997. PMID: 9195773 Review.
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N; MabThera International Trial (MInT) Group. Pfreundschuh M, et al. Lancet Oncol. 2011 Oct;12(11):1013-22. doi: 10.1016/S1470-2045(11)70235-2. Epub 2011 Sep 21. Lancet Oncol. 2011. PMID: 21940214 Clinical Trial.
Toxicity of chemotherapy.
Lowenthal RM, Eaton K. Lowenthal RM, et al. Hematol Oncol Clin North Am. 1996 Aug;10(4):967-90. doi: 10.1016/s0889-8588(05)70378-6. Hematol Oncol Clin North Am. 1996. PMID: 8811311 Review.
Alternative cancer treatments.
Lowenthal RM. Lowenthal RM. Med J Aust. 1996 Nov 18;165(10):536-7. doi: 10.5694/j.1326-5377.1996.tb138635.x. Med J Aust. 1996. PMID: 8941235 No abstract available.
Cold sweats.
Lowenthal RM, Taylor BV, Tan BS. Lowenthal RM, et al. Lancet. 2000 Dec 16;356(9247):2064. doi: 10.1016/s0140-6736(00)03404-8. Lancet. 2000. PMID: 11145493 No abstract available.
179 results